CN103212041A - Chinese medicinal composition treating coronary heart disease - Google Patents
Chinese medicinal composition treating coronary heart disease Download PDFInfo
- Publication number
- CN103212041A CN103212041A CN2013100937255A CN201310093725A CN103212041A CN 103212041 A CN103212041 A CN 103212041A CN 2013100937255 A CN2013100937255 A CN 2013100937255A CN 201310093725 A CN201310093725 A CN 201310093725A CN 103212041 A CN103212041 A CN 103212041A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition treating coronary heart disease. The Chinese medicinal composition is made of the following Chinese medicinal materials by weight: 10-40 parts of bighead atractylodes rhizome, 10-30 parts of Poria, 5-20 parts of Mangnolia officinalis, 3-10 parts of dried ginger, 5-15 parts of Parasitic Loranthus, 3-10 parts of panax notoginseng, 5-25 parts of Ligusticum wallichii, 2-5 parts of asarum, 5-20 parts of fructus psoraleae, 5-20 parts of Radix Ophiopogonis, 5-15 parts of cassia twigs, 10-30 parts of Salvia miltiorrhiza, 5-25 parts of Schisandra chinensis, 5-15 parts of pueraria, 5-20 parts of allium macrostemon, 5-20 parts of rhizoma corydalis, 5-25 parts of radix curcumae, 5-15 parts of rhizoma cyperi, and 5-15 parts of safflower. With the efficacy of soothing liver and dispelling stagnation, tonifying kidney and restoring yang, promoting blood circulation and smoothing veins, invigorating spleen and soothing nerves, the Chinese medicinal composition has obvious coronary heart disease treatment effects and reliable functions. The Chinese medicinal composition disclosed in the invention has the characteristics of wide ingredient medicine sources, simple preparation, mild medicine properties, and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of coronary heart disease.
Background technology
Coronary heart disease is the abbreviation of coronary heart disease, is common clinically frequently-occurring disease, commonly encountered diseases.Modern medicine is thought, coronary heart disease is because coronary atherosclerosis, or thrombosis is attached to causing coronary stricture on the coronary blood tube wall, reduce by coronary artery blood flow,, need blood volume to increase when the heart load increases suddenly, the compensatory capacity that has surpassed the coronary artery blood supply, or need blood volume not increase, but coronary spasm, reduced blood flow or above-mentioned factor exists simultaneously, all can cause heart sharply, temporary transient ischemia, anoxia and angina pectoris takes place.At present, the main treatment means one of doctor trained in Western medicine is the formation that prevents thrombosis with medicine, and it exists curative effect instability, the course of disease long, outbreak, the unfavorable deficiency of effect repeatedly; The 2nd, carry out coronary artery and expand art, but price is expensive, and certain risk is arranged, most of patients can not be accepted, and be subjected to the restriction of age and armarium again, can not extensively popularize.
The traditional Chinese medical science thinks that coronary heart disease mainly shows as deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive, and it is empty that its deficiency in origin can have yang blood and qi to lose, real is the stagnation of QI, cold coagulation, turbid, the blood stasis of expectorant, and again can be sick each other mutually, its pathogenesis is a blockage of the cardiac vessels, its sick position with the heart is and is relevant with liver,spleen,kidney three dirty functional disorders.
According to theory of Chinese medical science, at cause of coronary heart disease mechanism, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Have in order to overcome in the prior art prevention of treatment coronary heart disease Western medicine that curative effect is undesirable, the row coronary artery expands art and has expensive deficiency, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment coronary heart disease that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of coronary heart disease is characterized in that: it is to be made by following parts by weight of Chinese traditional medicine raw material: Rhizoma Atractylodis Macrocephalae 10-40 part, Poria 10-30 part, Cortex Magnoliae Officinalis 5-20 part, Rhizoma Zingiberis 3-10 part, Herba Taxilli 5-15 part, Radix Notoginseng 3-10 part, Rhizoma Chuanxiong 5-25 part, Herba Asari 2-5 part, Fructus Psoraleae 5-20 part, Radix Ophiopogonis 5-20 part, Ramulus Cinnamomi 5-15 part, Radix Salviae Miltiorrhizae 10-30 part, Fructus Schisandrae Chinensis 5-25 part, Radix Puerariae 5-15 part, Bulbus Allii Macrostemonis 5-20 part, Rhizoma Corydalis 5-20 part, Radix Curcumae 5-25 part, Rhizoma Cyperi 5-15 part, Flos Carthami 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of coronary heart disease is characterized in that: it is to be made by following parts by weight of Chinese traditional medicine raw material: 30 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Poria, 12 parts of Cortex Magnoliae Officinalis, 6 parts of Rhizoma Zingiberiss, 10 parts of Herba Taxillis, 6 parts of Radix Notoginseng, 15 parts of Rhizoma Chuanxiongs, 3 parts of Herba Asaris, 15 parts of Fructus Psoraleaes, 12 parts of Radix Ophiopogonis, 9 parts of Ramulus Cinnamomi, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Schisandrae Chinensis, 9 parts of Radix Puerariaes, 12 parts of Bulbus Allii Macrostemonis, 12 parts of Rhizoma Corydalis, 15 parts of Radix Curcumaes, 10 parts of Rhizoma Cyperis, 9 parts on Flos Carthami.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: the Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, the antiabortive effect of hidroschesis; Poria has spleen-benefiting mind-tranquilizing, calm diuretic effect; Cortex Magnoliae Officinalis has the circulation of qi promoting removing food stagnancy, dampness is removed effect full, lowering the adverse QI to relieve asthma; Rhizoma Zingiberis has that warming spleen and stomach for dispelling cold, recuperating depleted YANG are promoted blood circulation, the effect of warming the lung to resolve fluid-retention; Herba Taxilli has the effect of invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit; Radix Notoginseng has the effect of activating blood and removing stasis, hemostasis, reducing swelling and alleviating pain; Rhizoma Chuanxiong has the effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Herba Asari has the cold expelling that induces sweat, wind-expelling pain-stopping, warming the lung to resolve fluid-retention, sensible effect; Fructus Psoraleae has the effect of reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma; Has the effect that YIN nourishing and the production of body fluid promoting, lung moistening clear away heart-fire Radix Ophiopogonis; Ramulus Cinnamomi has the effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Radix Salviae Miltiorrhizae has the effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Fructus Schisandrae Chinensis has the effect of astringent or styptic treatment for spontaneous sweating, the supplementing QI for promoting the production of body fluid of convergence, kidney calming; Radix Puerariae has relieving muscles diaphoresis, invigorating YANG QI to promote eruption, analgesic effect of promoting the production of body fluid; Bulbus Allii Macrostemonis has the effect of activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving, the chest stuffiness relieving of regulating the flow of vital energy; Rhizoma Corydalis has promoting blood circulation to remove blood stasis, promoting the circulation of QI analgesic effect; Radix Curcumae has the effect of regulating qi to disperse stagnation, heart fire-clearing upset-relieving; Rhizoma Cyperi has liver-smoothing, qi-regulating
,Resolving depression analgesic effect; Flos Carthami has the effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain.The selected medicament composing prescription of the present invention, its drug component be through dialectical compatibility, helps using mutual assistant, plays the effect of soothing liver-QI for relieving depression, the kidney invigorating recuperating depleted YANG, blood circulation and channel invigorating, spleen-benefiting mind-tranquilizing altogether, and the treatment of coronary heart disease is reached treating both the principal and the secondary aspects of a disease at the same time.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.The present invention follows the prescription principle of medication of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 90.7%, cure rate 46.2%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of coronary heart disease, it is to be made by following Chinese medicine raw materials by weight proportion: Rhizoma Atractylodis Macrocephalae 30g, Poria 20g, Cortex Magnoliae Officinalis 12g, Rhizoma Zingiberis 6g, Herba Taxilli 10g, Radix Notoginseng 6g, Rhizoma Chuanxiong 15g, Herba Asari 3g, Fructus Psoraleae 15g, Radix Ophiopogonis 12g, Ramulus Cinnamomi 9g, Radix Salviae Miltiorrhizae 20g, Fructus Schisandrae Chinensis 15g, Radix Puerariae 9g, Bulbus Allii Macrostemonis 12g, Rhizoma Corydalis 12g, Radix Curcumae 15g, Rhizoma Cyperi 10g, Flos Carthami 9g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of coronary heart disease, it is to be made by following Chinese medicine raw materials by weight proportion: Rhizoma Atractylodis Macrocephalae 20g, Poria 30g, Cortex Magnoliae Officinalis 5g, Rhizoma Zingiberis 10g, Herba Taxilli 5g, Radix Notoginseng 10g, Rhizoma Chuanxiong 25g, Herba Asari 2g, Fructus Psoraleae 10g, Radix Ophiopogonis 5g, Ramulus Cinnamomi 10g, Radix Salviae Miltiorrhizae 15g, Fructus Schisandrae Chinensis 5g, Radix Puerariae 10g, Bulbus Allii Macrostemonis 15g, Rhizoma Corydalis 10g, Radix Curcumae 20g, Rhizoma Cyperi 5g, Flos Carthami 10g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of coronary heart disease, it is to be made by following Chinese medicine raw materials by weight proportion: Rhizoma Atractylodis Macrocephalae 40g, Poria 10g, Cortex Magnoliae Officinalis 15g, Rhizoma Zingiberis 5g, Herba Taxilli 8g, Radix Notoginseng 3g, Rhizoma Chuanxiong 10g, Herba Asari 4g, Fructus Psoraleae 12g, Radix Ophiopogonis 20g, Ramulus Cinnamomi 5g, Radix Salviae Miltiorrhizae 25g, Fructus Schisandrae Chinensis 10g, Radix Puerariae 5g, Bulbus Allii Macrostemonis 20g, Rhizoma Corydalis 15g, Radix Curcumae 5g, Rhizoma Cyperi 12g, Flos Carthami 5g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of coronary heart disease, it is to be made by following Chinese medicine raw materials by weight proportion: Rhizoma Atractylodis Macrocephalae 10g, Poria 25g, Cortex Magnoliae Officinalis 20g, Rhizoma Zingiberis 8g, Herba Taxilli 15g, Radix Notoginseng 5g, Rhizoma Chuanxiong 5g, Herba Asari 5g, Fructus Psoraleae 20g, Radix Ophiopogonis 15g, Ramulus Cinnamomi 12g, Radix Salviae Miltiorrhizae 30g, Fructus Schisandrae Chinensis 20g, Radix Puerariae 12g, Bulbus Allii Macrostemonis 5g, Rhizoma Corydalis 20g, Radix Curcumae 10g, Rhizoma Cyperi 15g, Flos Carthami 15g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of coronary heart disease, it is to be made by following Chinese medicine raw materials by weight proportion: Rhizoma Atractylodis Macrocephalae 25g, Poria 15g, Cortex Magnoliae Officinalis 10g, Rhizoma Zingiberis 3g, Herba Taxilli 12g, Radix Notoginseng 9g, Rhizoma Chuanxiong 20g, Herba Asari 3g, Fructus Psoraleae 5g, Radix Ophiopogonis 10g, Ramulus Cinnamomi 15g, Radix Salviae Miltiorrhizae 10g, Fructus Schisandrae Chinensis 25g, Radix Puerariae 15g, Bulbus Allii Macrostemonis 10g, Rhizoma Corydalis 5g, Radix Curcumae 25g, Rhizoma Cyperi 9g, Flos Carthami 12g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 6 centimetres of powder, decoct, at a simmer preceding employing intense fire decocts, and slow fire boiling 20～30 minutes are used in the back of boiling; Second decocts, and adds water and does not have about 5 centimetres of powder, decocts, and decocts 15～20 minutes after water boils.Decoct extracting juice twice, merge.
A kind of Chinese medicine composition for the treatment of coronary heart disease, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 65 examples, male 31 examples, women 34 examples, 30～70 years old age.
Two, diagnosis basis:
1, Danzhong or the pareordia pain of feeling oppressed, very then positions such as the thorough left side of the pain shoulder back of the body, throat, left upper arm inboard.Being ictal or lasting does not understand.Often with shortness of breath and palpitation, spontaneous perspiration, very then failing to sleep due to dyspnea;
2, general several seconds of feeling of oppression and pain in the chest is alleviated to dozens of minutes.But the severe patient sharp ache continue not to be understood, cold extremities due to sweating, and pale complexion, cyanosis of the lips and nails, palpitating speed, or crisis such as arrhythmia can be died suddenly;
3, be more common in above middle age, often because of overworking, depressed angry or polydipsia gluttony, impression is cold and bring out;
4, look into electrocardiogram, ambulatory electrocardiogram, exercise test etc. to clarify a diagnosis.Make myocardial enzymes in case of necessity and measure, electrocardiogram dynamic observes.
Three, usage and dosage: during clinical practice, the component in the compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.Potion on the one, the about 300ml of twice extracting juice of decocting divides early, takes for late twice.Seven pairs is a course of treatment.
Four,, criterion of therapeutical effect:
(1) cure: transference cure, electrocardiogram and relevant lab testing recover normal;
(2) take a turn for the better: sx, attack times reduces, and the intermission prolongs, and lab testing has improvement;
(3) do not heal: cardinal symptom and electrocardiogram do not have change.
Five, therapeutic effect: in this clinical observation case, take medicine 3-10 the course of treatment, cure 30 examples, follow up a case by regular visits to and do not see recurrence; 29 examples that take a turn for the better, 6 examples more.Toxic and side effects does not take place during the treatment.
Six, model case:
Case 1:
Zhang, man, 47 years old.Private prosecution: dizzy 3 years uncomfortable in chest surplus, increased the weight of for 2 weeks.Examine and see: cardiopalmus, uncomfortable in chest, dizzy, weak, aversion to cold and cold limbs, loose stool, edema of lower limbs, lustreless complexion, words are purple dark, thin white fur of tongue, deep-slow pulse and thin.Examine and be coronary heart disease.Take 2 courses of treatment of medicament of Chinese medicine composition preparation of the present invention, uncomfortable in chest, cardiopalmus alleviates, and stool is shaped; Continue to take 5 courses of treatment, all diseases disappear, and cure.
Case 2:
Late certain, man, 51 years old.Because of the pareordia discomfort, uncomfortable in chest nervous, examination in hospital is examined and is coronary heart disease to take a favorable turn slightly through the western medical treatment symptom.The first quarter moon cause is busy with one's work, and operating pressure is big, burst precordialgia, fixing companion's pain uncomfortable in chest, cardiopalmus, the malaise of not moving.Take 3 courses of treatment of medicament of Chinese medicine composition preparation of the present invention, pain uncomfortable in chest, weak sx; Continue and obey 2 courses of treatment, recurrence again half a year is followed up a case by regular visits in the symptom complete obiteration.
Claims (2)
1. Chinese medicine composition for the treatment of coronary heart disease, it is characterized in that: it is to be made by following parts by weight of Chinese traditional medicine raw material: Rhizoma Atractylodis Macrocephalae 10-40 part, Poria 10-30 part, Cortex Magnoliae Officinalis 5-20 part, Rhizoma Zingiberis 3-10 part, Herba Taxilli 5-15 part, Radix Notoginseng 3-10 part, Rhizoma Chuanxiong 5-25 part, Herba Asari 2-5 part, Fructus Psoraleae 5-20 part, Radix Ophiopogonis 5-20 part, Ramulus Cinnamomi 5-15 part, Radix Salviae Miltiorrhizae 10-30 part, Fructus Schisandrae Chinensis 5-25 part, Radix Puerariae 5-15 part, Bulbus Allii Macrostemonis 5-20 part, Rhizoma Corydalis 5-20 part, Radix Curcumae 5-25 part, Rhizoma Cyperi 5-15 part, Flos Carthami 5-15 part.
2. a kind of Chinese medicine composition for the treatment of coronary heart disease according to claim 1 is characterized in that: it is to be made by following parts by weight of Chinese traditional medicine raw material: 30 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Poria, 12 parts of Cortex Magnoliae Officinalis, 6 parts of Rhizoma Zingiberiss, 10 parts of Herba Taxillis, 6 parts of Radix Notoginseng, 15 parts of Rhizoma Chuanxiongs, 3 parts of Herba Asaris, 15 parts of Fructus Psoraleaes, 12 parts of Radix Ophiopogonis, 9 parts of Ramulus Cinnamomi, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Schisandrae Chinensis, 9 parts of Radix Puerariaes, 12 parts of Bulbus Allii Macrostemonis, 12 parts of Rhizoma Corydalis, 15 parts of Radix Curcumaes, 10 parts of Rhizoma Cyperis, 9 parts on Flos Carthami.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310093725.5A CN103212041B (en) | 2013-03-22 | 2013-03-22 | Chinese medicinal composition treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310093725.5A CN103212041B (en) | 2013-03-22 | 2013-03-22 | Chinese medicinal composition treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103212041A true CN103212041A (en) | 2013-07-24 |
| CN103212041B CN103212041B (en) | 2015-03-11 |
Family
ID=48810427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310093725.5A Expired - Fee Related CN103212041B (en) | 2013-03-22 | 2013-03-22 | Chinese medicinal composition treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103212041B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977244A (en) * | 2014-06-06 | 2014-08-13 | 任杰 | Traditional Chinese medicine for treating coronary heart disease |
| CN105749158A (en) * | 2016-03-16 | 2016-07-13 | 曲思廉 | Traditional Chinese medicine for treating coronary heart disease |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1383846A (en) * | 2001-04-29 | 2002-12-11 | 王运景 | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
| CN101057946A (en) * | 2007-05-09 | 2007-10-24 | 王云花 | Traditional Chinese medicine for treating heart disease |
| CN101181600A (en) * | 2007-11-20 | 2008-05-21 | 王振才 | Traditional chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
| CN101249250A (en) * | 2008-03-24 | 2008-08-27 | 李运乃 | Medicinal liquor preparation for treating thoracic obstruction and chest pain caused by cold phlegm, qi stagnation, blood stasis and collateral obstruction |
| CN101468148A (en) * | 2007-12-27 | 2009-07-01 | 郭太平 | Chinese medicinal composition for treating coronary heart disease and cerebral arteriosclerosis, and method for preparing the same |
-
2013
- 2013-03-22 CN CN201310093725.5A patent/CN103212041B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1383846A (en) * | 2001-04-29 | 2002-12-11 | 王运景 | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN101057946A (en) * | 2007-05-09 | 2007-10-24 | 王云花 | Traditional Chinese medicine for treating heart disease |
| CN101181600A (en) * | 2007-11-20 | 2008-05-21 | 王振才 | Traditional chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
| CN101468148A (en) * | 2007-12-27 | 2009-07-01 | 郭太平 | Chinese medicinal composition for treating coronary heart disease and cerebral arteriosclerosis, and method for preparing the same |
| CN101249250A (en) * | 2008-03-24 | 2008-08-27 | 李运乃 | Medicinal liquor preparation for treating thoracic obstruction and chest pain caused by cold phlegm, qi stagnation, blood stasis and collateral obstruction |
Non-Patent Citations (2)
| Title |
|---|
| 李青 等: ""詹文涛教授辨证论治冠心病经验（二）"", 《中国中医急症》 * |
| 竺培华: ""应用中医整体观理论治疗冠心病心绞痛的体会"", 《上海中医药杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103977244A (en) * | 2014-06-06 | 2014-08-13 | 任杰 | Traditional Chinese medicine for treating coronary heart disease |
| CN103977244B (en) * | 2014-06-06 | 2016-09-28 | 吴军 | A kind of Chinese medicine treating coronary heart disease |
| CN105749158A (en) * | 2016-03-16 | 2016-07-13 | 曲思廉 | Traditional Chinese medicine for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103212041B (en) | 2015-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078510B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN103316204B (en) | One treats hypertensive Chinese medicine composition | |
| CN102357177B (en) | Traditional Chinese medicine for curing climacteric metancholia | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN103007192B (en) | Chinese medicinal composition for treating thoracic obstruction | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN105395911A (en) | Traditional Chinese medicine for curing cerebral thrombosis | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103007213A (en) | Chinese medicinal composition for treating arthralgia | |
| CN102430084A (en) | Traditional Chinese medicine composition for treating arthralgia syndrome | |
| CN103212044B (en) | Traditional Chinese medicine composition for treating cardiovascular diseases | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102430030A (en) | Traditional Chinese medicine composition for treating bone rheumatism | |
| CN105079768A (en) | Traditional Chinese medicine composition for treating coronary heart disease caused by syndrome of phlegm obstruction | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN103550689B (en) | A kind of Chinese medicine composition for the treatment of the thoracic obstruction | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: DONG WEI Free format text: FORMER OWNER: SUN SHENGBO Effective date: 20150210 |
|
| C14 | Grant of patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Dong Wei Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: DONG WEI SUN SHENGBO |
|
| GR01 | Patent grant | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150210 Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 (Rongcheng City Hospital) Applicant after: Dong Wei Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Sun Shengbo |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 Termination date: 20160322 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |